Driving Science through Open Innovation
The Information Daily website notes that providing tools and information for academics in the public domain can lead to faster publication and drug creation, benefiting the whole scientific community, according to Malcolm Skingle of GlaxoSmithKline. In the article Skingle discusses the opportunities of open innovation in scientific research.
Click here to read the full article.